These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29706764)

  • 1. The Dilemma of Service Productivity and Service Innovation: An Empirical Exploration in Financial Services.
    Aspara J; Klein JF; Luo X; Tikkanen H
    J Serv Res; 2018 May; 21(2):249-262. PubMed ID: 29706764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantity or quality? The impact of financial geo-density on firms' green innovation.
    Li S; Chen L; Xu P
    Environ Sci Pollut Res Int; 2023 Apr; 30(18):54073-54094. PubMed ID: 36869960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discretionary Effort on Green Technology Innovation: How Chinese Enterprises Act when Facing Financing Constraints.
    Zhang K; Liu X; Hong M
    PLoS One; 2021; 16(12):e0261589. PubMed ID: 34936690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Guidance' or 'Misleading'? The government subsidy and the choice of enterprise innovation strategy.
    Ding J; Wang J; Liu B; Peng L
    Front Psychol; 2022; 13():1005563. PubMed ID: 36267081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are firms' voluntary environmental management activities beneficial for the environment and business? An empirical study focusing on Japanese manufacturing firms.
    Nishitani K; Kaneko S; Fujii H; Komatsu S
    J Environ Manage; 2012 Aug; 105():121-30. PubMed ID: 22542980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competitor-Weighted Centrality and Small-World Clusters in Competition Networks on Firms' Innovation Ambidexterity: Evidence from the Wind Energy Industry.
    Zhao R; Zhang H; Zhang MY; Qu F; Xu Y
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stakeholder network for developing open innovation practice of China's manufacturing enterprises.
    Lyu B; Yi R; Fan G; Zhang Y
    Heliyon; 2023 Mar; 9(3):e13192. PubMed ID: 37101472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Golden ratio-based capital structure as a tool for boosting firm's financial performance and market acceptance.
    Ulbert J; Takács A; Csapi V
    Heliyon; 2022 Jun; 8(6):e09671. PubMed ID: 35734561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Firm productivity, pollution, and output: theory and empirical evidence from China.
    Tang E; Zhang J; Haider Z
    Environ Sci Pollut Res Int; 2015 Nov; 22(22):18040-6. PubMed ID: 26169823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Firm's Unethical Behavior in Investment Decisions Among Young Investors in China.
    Tang X; Yu K; Yu W
    Psychol Res Behav Manag; 2022; 15():3427-3443. PubMed ID: 36466762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding cognitive differences in the effect of digitalization on ambidextrous innovation: Moderating role of industrial knowledge base.
    Xu Q; Liu H; Chen Y; Tian K
    Front Psychol; 2022; 13():983844. PubMed ID: 36176792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How Do Green Innovation Strategies Contribute to Firm Performance Under Supply Chain Risk? Evidence From China's Manufacturing Sector.
    Wang M; Liu Z
    Front Psychol; 2022; 13():894766. PubMed ID: 35572315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does External Knowledge Sourcing Enhance Market Performance? Evidence from the Korean Manufacturing Industry.
    Lee K; Yoo J; Choi M; Zo H; Ciganek AP
    PLoS One; 2016; 11(12):e0168676. PubMed ID: 28006022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insurers' intervention, separation of two rights and firm's technology innovation.
    Xu B; Hao F
    Front Public Health; 2023; 11():1181219. PubMed ID: 37124801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Financing Constraints and Firm's Productivity Under the COVID-19 Epidemic Shock: Evidence of A-Shared Chinese Companies.
    Wong Z; Chen A; Taghizadeh-Hesary F; Li R; Kong Q
    Eur J Dev Res; 2023; 35(1):167-195. PubMed ID: 35194343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of psychological contract breach on firm's innovative performance: A moderated mediation model.
    Zhang L
    Front Psychol; 2022; 13():970622. PubMed ID: 36092046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dialect diversity and total factor productivity: Evidence from Chinese listed companies.
    Xiong J; Chen L
    Front Psychol; 2022; 13():1017397. PubMed ID: 36438310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resource-based theory of competitive advantage - a framework for pharmacy practice innovation research.
    Holdford DA
    Pharm Pract (Granada); 2018; 16(3):1351. PubMed ID: 30416633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innovation to Immune: Empirical Evidence From COVID-19 Focused Enterprise Surveys.
    Khan K; Liu S; Xiong B; Zhang L; Li C
    Front Psychol; 2022; 13():850842. PubMed ID: 35432097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovation concentration in knowledge network.
    Zheng J
    PLoS One; 2022; 17(4):e0266530. PubMed ID: 35385521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.